the law goes into effect before the patent protection expires.
plus I believe people should have their choice in medicines, particularly if it's something they're used to already and they do well with.
A delay until the patent protection expires would only keep Primatene Mist on the market a year or two longer. If there was enough of a market to be worth the cost of developing it, a non-CFC epinephrine inhaler would have been developed. There isn't because albuterol is a superior drug for this use.
True - but that doesn't negate the problem in the meantime, as a delay isn't going to happen right now. I don't know if the Montreal Protocol establishes the date for this or if its US policy as part of a plan to reach a goal at a later date.
I am support policies to reduce CFC's, and glad we've made some progress here as on other pollution issues. But this idea that a substance is supposed to be completely eliminated, that there is never an occasion that could justify it's use, is wrongheaded.
